When treatments such as medication and therapy aren’t able to relieve the symptoms of depression or another mental health condition, there are other options available. A psychiatrist might suggest ...
Detailed price information for Nrx Pharmaceuticals Inc (NRXP-Q) from The Globe and Mail including charting and trades.
New research supports the therapeutic potential of repetitive transcranial magnetic stimulation (rTMS) for Alzheimer’s disease (AD). In a 52-week phase 2 trial, personalized rTMS applied over the ...
MedPage Today on MSN
FDA approves at-home device for treatment-resistant depression
The FDA approved a prescription at-home brain neuromodulation therapy as an adjunctive depression treatment for adults, maker ...
18d
Brain Treatment USA Releases Expanded Case Narrative and Research Overview on rTMS in Autism Studies
A family case narrative and recent research highlight how EEG-guided rTMS is being studied in autism research. WIMBERLEY, TX, UNITED STATES, December 30, 2025 /EINPresswire.com/ — Brain Treatment USA ...
A clinic in Bellevue talks about transcranial magnetic stimulation. The new technology is becoming more widely available to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback